Medincell SA (MEDCL) EUR0.5

Sell:€19.98Buy:€20.38€0.71 (3.65%)

Prices delayed by at least 15 minutes
Sell:€19.98
Buy:€20.38
Change:€0.71 (3.65%)
Prices delayed by at least 15 minutes
Sell:€19.98
Buy:€20.38
Change:€0.71 (3.65%)
Prices delayed by at least 15 minutes

Company Information

About this company

Medincell SA is a France-based manufacturer of biological products and pharmaceutical preparations. The Company is focused on the development of therapeutic solutions with worldwide access. The Company works on both for-profit and non-profit projects, in collaboration with partners ranging from pharmaceutical corporations to physicians, from biotechnology firms to academics and foundations. Its range of products consists of three products in development phase: mdc-IRM, a subcutaneous injection in phase III clinical study for the treatment of schizophrenia; mdc-CWM, an intra-articular injection in phase II clinical study for the treatment of post-surgical pain and inflammation; mdc-TJK, a subcutaneous injection for the treatment of schizophrenia, as well as a number of other products that are in the research phase, such as mdc-WWM, which is a subcutaneous injection for contraception, and mdc-ELK, a subcutaneous injection for the treatment of depression, among others.

Key people

Christophe Douat
Chief Executive Officer, Executive Director
Stephane Postic
Chief Financial Officer
Philippe Moyen
Chief Operating Officer
Franck Pouzache
Chief People Officer
Julie Alimi
General Counsel, Chief Corporate Development Officer
Sebastien Enault
Chief Business Officer
Adolfo Lopez-Noriega
Head - Research and Development
Richard Malamut
Chief Medical Officer
Philippe Guy
Non-Executive Chairman of the Board
Elisabeth Kogan
Non-Executive Independent Vice Chairman of the Board
Tone Kvale
Non-Executive Independent Director
Virginie Lleu
Non-Executive Independent Director
Pascal Touchon
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    MEDCL
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    FR0004065605
  • Market cap
    €643.74m
  • Employees
    140
  • Shares in issue
    33.07m
  • Exchange
    Euronext Paris
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.